Clinical Trial Update: MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035) [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing MK-7625A plus metronidazole vs meropenem in pediatric patients with complicated intra-abdominal infection has completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Drugs mentioned

• METRONIDAZOLE (Metronidazole)
• MK-7625A
• Meropenem (Meropenem)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Complicated Intra-Abdominal Infection | Phase 2 | Status: COMPLETED | Results posted: 2021-12-21